Equities researchers at Brookline Capital Acquisition began coverage on shares of electroCore (NASDAQ:ECOR – Get Rating) in a report issued on Friday, Benzinga reports. The firm set a "buy" rating on the stock.

Separately, Berenberg Bank decreased their target price on shares of electroCore from GBX 390 ($4.75) to GBX 330 ($4.02) and set a "buy" rating for the company in a research note on Thursday, October 6th. Five investment analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock has an average rating of "Buy" and an average price target of $111.42.

electroCore Stock Performance

Shares of NASDAQ ECOR opened at $0.30 on Friday. electroCore has a 12 month low of $0.20 and a 12 month high of $0.90. The company has a 50 day simple moving average of $0.30 and a two-hundred day simple moving average of $7.80. The stock has a market cap of $21.49 million, a price-to-earnings ratio of -0.97 and a beta of 0.93.

Insiders Place Their Bets

In related news, Director Joseph P. Errico acquired 100,000 shares of electroCore stock in a transaction on Tuesday, December 13th. The stock was bought at an average cost of $0.33 per share, for a total transaction of $33,000.00. Following the completion of the transaction, the director now owns 2,724,841 shares of the company's stock, valued at approximately $899,197.53. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Over the last ninety days, insiders purchased 670,000 shares of company stock worth $186,650. Company insiders own 13.11% of the company's stock.

Hedge Funds Weigh In On electroCore

A number of large investors have recently added to or reduced their stakes in ECOR. Virtu Financial LLC acquired a new position in electroCore during the first quarter worth $53,000. Millennium Management LLC grew its holdings in shares of electroCore by 173.3% during the second quarter. Millennium Management LLC now owns 119,707 shares of the company's stock worth $61,000 after buying an additional 75,908 shares in the last quarter. Jaffetilchin Investment Partners LLC grew its holdings in shares of electroCore by 31.6% during the first quarter. Jaffetilchin Investment Partners LLC now owns 307,984 shares of the company's stock worth $82,000 after buying an additional 74,000 shares in the last quarter. Renaissance Technologies LLC grew its holdings in shares of electroCore by 102.2% during the second quarter. Renaissance Technologies LLC now owns 262,848 shares of the company's stock worth $134,000 after buying an additional 132,848 shares in the last quarter. Finally, Wealthspire Advisors LLC grew its holdings in shares of electroCore by 40.0% during the second quarter. Wealthspire Advisors LLC now owns 700,000 shares of the company's stock worth $357,000 after buying an additional 200,000 shares in the last quarter. 17.76% of the stock is currently owned by institutional investors and hedge funds.

electroCore Company Profile

(Get Rating)

electroCore, Inc, a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults.

Featured Stories

• Get a free copy of the StockNews.com research report on electroCore (ECOR)
• MarketBeat: Week in Review 01/09-01/13
• JPMorgan Chase Falls As Banks Brace For Recession
• Why is the Bed Bath & Beyond Stock Price up 261%?
• Roku Stock Price is Trending, Here's Why
• Carvana Stock Rally, Here's What You Need to Know

Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.